Eli Lilly Net Income 2006-2018 | LLY

Eli Lilly annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Eli Lilly net income for the quarter ending September 30, 2018 was $1.150B, a 106.89% increase year-over-year.
  • Eli Lilly net income for the twelve months ending September 30, 2018 was $0.450B, a 79.77% decline year-over-year.
  • Eli Lilly annual net income for 2017 was $-0.204B, a 107.46% decline from 2016.
  • Eli Lilly annual net income for 2016 was $2.738B, a 13.67% increase from 2015.
  • Eli Lilly annual net income for 2015 was $2.408B, a 0.75% increase from 2014.
Eli Lilly Annual Net Income
(Millions of US $)
2017 $-204
2016 $2,738
2015 $2,408
2014 $2,391
2013 $4,685
2012 $4,089
2011 $4,348
2010 $5,070
2009 $4,329
2008 $-2,072
2007 $2,953
2006 $2,663
2005 $1,980
Eli Lilly Quarterly Net Income
(Millions of US $)
Q3 2018 $1,150
Q2 2018 $-260
Q1 2018 $1,217
Q4 2017 $-1,657
Q3 2017 $556
Q2 2017 $1,008
Q1 2017 $-111
Q4 2016 $772
Q3 2016 $778
Q2 2016 $748
Q1 2016 $440
Q4 2015 $478
Q3 2015 $800
Q2 2015 $601
Q1 2015 $530
Q4 2014 $429
Q3 2014 $501
Q2 2014 $734
Q1 2014 $728
Q4 2013 $728
Q3 2013 $1,203
Q2 2013 $1,206
Q1 2013 $1,548
Q4 2012 $827
Q3 2012 $1,327
Q2 2012 $924
Q1 2012 $1,011
Q4 2011 $858
Q3 2011 $1,236
Q2 2011 $1,197
Q1 2011 $1,056
Q4 2010 $1,170
Q3 2010 $1,303
Q2 2010 $1,349
Q1 2010 $1,248
Q4 2009 $915
Q3 2009 $942
Q2 2009 $1,159
Q1 2009 $1,313
Q4 2008 $-3,629
Q3 2008 $-466
Q2 2008 $959
Q1 2008 $1,064
Q4 2007 $854
Q3 2007 $926
Q2 2007 $664
Q1 2007 $509
Q4 2006 $132
Q3 2006 $874
Q2 2006 $822
Q1 2006 $835
Q4 2005 $701
Q3 2005 $794
Q2 2005 $-252
Q1 2005 $737
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $122.680B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $396.345B 18.58
Pfizer (PFE) United States $262.998B 14.83
Merck (MRK) United States $205.854B 17.84
Novartis AG (NVS) Switzerland $204.655B 17.49
AbbVie (ABBV) United States $134.597B 11.95
Sanofi (SNY) France $112.713B 13.96
Novo Nordisk (NVO) Denmark $111.107B 18.04
AstraZeneca (AZN) United Kingdom $103.342B 12.83
GlaxoSmithKline (GSK) United Kingdom $101.256B 13.61
Bristol-Myers Squibb (BMY) United States $87.290B 14.38